US 10370430
Recombinant factor VIII proteins
granted A61KA61K35/14A61K38/00
Quick answer
US patent 10370430 (Recombinant factor VIII proteins) held by BIOVERATIV THERAPEUTICS INC. expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K35/14, A61K38/00, A61K38/37, A61P